Skip to main content
← Pulse
Pulse · Daily edition№ 095

Monday, 7 September 2026

European deeptech and defence industries are drawing significant investment and facing strategic policy debates, from new growth debt funds to questions of industrial capacity and tech sovereignty.

The number

€575M

Claret Capital Partners has closed its fourth European Growth Capital Fund, exceeding its target for growth debt for European innovators.

Listen — today's brief

Welcome to EU Pulse. Today, we're examining Europe's deep tech and defense industries, which are drawing significant investment and facing strategic policy debates. Indeed. Our number of the day, five hundred and seventy-five million dollars, highlights Claret Capital Partners' fourth European Growth Capital Fund. They exceeded their target for providing growth debt to European innovators. That's a strong signal of private capital interest in the region's innovation ecosystem. But while investment flows, Europe's defense industry faces mounting pressure. Kyiv's push for faster military aid is straining industrial capacity. Reports highlight struggles to scale production, with projects like IDEALIST supporting SMEs in defense to tackle supply chain disruptions. Beyond defense, energy security is a major driver, with nuclear power seeing renewed focus across the continent. Eurenco, a key uranium enrichment firm, reports a tripling of orders for enriched uranium. This surge, covering next-generation fuels, reflects Europe's strategic shift towards energy independence. This push is critical given the uncertainty of Russian and US nuclear fuel supplies, necessitating independent supply chains. Exactly. The demand for specialized fuels like HALEU for research reactors and medical radioisotopes further underscores this strategic shift. And finally, the discussion around European tech sovereignty, particularly in AI, continues to shape digital policy. Absolutely. While a distinct European AI infrastructure is proposed, the broader ambition is to cultivate independent technological capabilities, prioritizing sustainability over ever-larger data centers. Significant financial commitments like Claret Capital's fund are crucial for fostering advanced technologies and strengthening Europe's competitive edge in this domain. These investments are vital for bridging gaps between innovation leader regions and emerging innovators, translating scientific knowledge into business opportunities. Crucial insights into Europe's strategic priorities for investment and industrial capacity. That's all for today's EU Pulse. Find today's full edition, number ninety-five, at eu.eu.

  1. Growth Debt

    Claret Capital raises €575M for European innovators' growth debt

    Claret Capital Partners has closed its fourth European Growth Capital Fund at €575 million, surpassing its €500 million target. This fund will provide growth debt to European innovators, signaling continued private capital interest in the region's deeptech and innovation ecosystem.

    Read article →

  2. Defence Capacity

    Europe's Defence Industry Strains Under Ukraine War Demand

    Kyiv's push for faster military aid delivery is testing Europe's defence industrial capacity. The bloc's ability to scale up production and address supply chain vulnerabilities remains a critical challenge amidst ongoing conflict.

    Read article →

  3. Nuclear Energy

    Urenco Sees Tripled Uranium Orders Amid Energy Security Push

    Urenco, a key uranium enrichment firm, reports a significant increase in orders for enriched uranium, driven by heightened energy security concerns and demand for next-generation fuels. This indicates a growing reliance on nuclear power in Europe, potentially impacting industrial and energy policy.

    Read article →

  4. AI Sovereignty

    European AI Model Lacks Specifics in Available Research

    While an alternative European approach to AI infrastructure is proposed, details regarding specific proponents and their vision for tech sovereignty and sustainability are not available in recent market signals.

    Read article →

  5. Pharma Policy

    German pharmaceutical industry intensifies pressure over drug costs

    The German pharmaceutical industry is increasing its lobbying efforts against drug cost regulation. This move is influenced by international pricing policies and signals ongoing tension between healthcare cost control and industry demands.

    Read article →

  6. Growth Capital

    Claret Capital Closes €575M Growth Debt Fund for European Innovators

    Claret Capital Partners has successfully closed its fourth European Growth Capital Fund, surpassing its target with €575 million. This significant fund will provide growth debt to European innovators, boosting the region's financial services sector.

    Read article →

Get Pulse daily